Source: Endpoints News

Abeona: FDA approves Abeona's skin disease cell therapy

Abeona Therapeutics received FDA approval for its cell therapy to treat "butterfly skin," a rare genetic disease that causes fragile skin and wounds. And its price tag makes it one of the most expensive therapies ...

Read full article »
Annual Revenue
$100K-5.0M
Employees
100-250
Vishwas Seshadri's photo - President & CEO of Abeona

President & CEO

Vishwas Seshadri

CEO Approval Rating

83/100

Read more